TL;DR
This paper introduces a novel framework for modeling complex infectious diseases by combining continuous and discrete dynamics into "hybrid dynamical systems." This approach allows for more realistic simulations of disease progression and the development of optimal, multi-stage treatment strategies, particularly for diseases like osteomyelitis that operate on multiple biological scales.
What Problem Does This Paper Address?
Understanding and treating complex diseases, especially infectious ones, is a significant challenge due to their multiscale nature. Diseases can manifest at the molecular, cellular, tissue, organ, and population levels, and their progression involves both continuous biological processes and discrete events (like drug administration or immune responses). Traditional modeling approaches often struggle to capture this heterogeneity, making it difficult to predict disease spread and design effective interventions. This paper addresses the need for a unified modeling framework that can integrate these diverse scales and dynamics to better understand disease mechanisms and optimize treatment strategies.
Methods
The authors propose a "hybrid modeling" approach, which they define in two ways:
- Classical Hybrid Systems: Modeling systems with both continuous and discrete dynamics.
- Methodological Hybridity: Combining different modeling techniques suitable for various biological scales (e.g., agent-based models for cells, differential equations for populations).
They introduce a formal language called Disease Chemical Ground Form (D-CGF), a variant of process algebra, to describe these complex disease processes. D-CGF allows for the specification of:
- Species: Representing different compartments of a disease model (e.g., susceptible, infected, recovered individuals) or pathogens. These are interpreted as continuous variables in the hybrid semantics.
- Therapies: Representing interventions like drug dosages or treatment schedules. These are interpreted as discrete switches.
From a D-CGF specification, they derive a hybrid dynamical system semantics. This involves:
- Stoichiometric Matrix: Capturing the rates of change for different species based on reactions.
- Switching Therapies (STs): Identifying discrete control states that represent combinations of active therapies.
- Mode Graph: Representing the possible combinations of therapy states.
This framework allows them to translate the D-CGF model into a Controlled Switched System (CSS), which is a type of hybrid dynamical system. They then apply Model Predictive Control (MPC) to compute optimal therapy scheduling strategies.
Datasets
Not discussed in the paper. The paper uses simulated data and theoretical examples (SIR model, osteomyelitis model) for demonstration.
Key Insights and Ideas
- Unified Multiscale Modeling: The D-CGF language provides a single, formal framework to describe disease dynamics across multiple biological scales, bridging the gap between different modeling techniques.
- Therapies as Discrete Switches: Explicitly modeling therapies as discrete events within a continuous disease model allows for the analysis of complex treatment schedules and their impact.
- Formalizing Treatment Optimization: The combination of hybrid modeling and control theory (MPC) offers a rigorous way to find optimal, time-varying treatment strategies, considering potential side effects and drug interactions.
- Osteomyelitis as a Case Study: The application to osteomyelitis highlights the framework's ability to model diseases with complex interactions between pathogen dynamics and host biological processes (bone remodeling).
Key Results
The paper demonstrates the framework's utility through:
- SIR Model Analysis: They show how to derive ODEs from a D-CGF specification and how to incorporate therapies (T1 and T2) as discrete inputs. They present simulation results of optimal therapy scheduling for the SIR model under different penalty scenarios for drug usage, illustrating how MPC can determine when and how to administer therapies.
- Osteomyelitis Model: They present a hybrid model for osteomyelitis, incorporating bacterial population dynamics and bone remodeling processes, and suggest how their control framework could be applied to optimize antibiotic and anti-inflammatory therapies.
Limitations and Future Work
- Computational Complexity: While the framework is powerful, deriving and simulating hybrid dynamical systems can be computationally intensive, especially for very large or complex models.
- Parameter Calibration: Accurately calibrating the numerous parameters required for these multiscale models remains a significant challenge in real-world applications.
- Generalizability: While the framework is presented as general, its application to a wider range of diseases and biological scales would require further validation.
- Future Work: The authors suggest extending the framework to more complex tissues and organs, incorporating hierarchical therapy protocols, and exploring the interplay between natural biological controls (like the immune system) and externally imposed treatments. They also pose a philosophical question: "Ask not what mathematics can do for biology. Ask what biology can do for Mathematics," suggesting that biological complexity can inspire new mathematical theories.
Summary updated